Jump Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Jump Financial’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,170	Closed	-$370K	–	2417
2023 Q4	$370K	Sell	1,170 -2,035	-63%	-$396K	0.01%	1223
2023 Q3	$542K	Buy	3,205 +65	+2%	+$12.2K	0.02%	977
2023 Q2	$681K	Buy	+3,140	New	+$673K	0.03%	880
2022 Q4	–	Sell	-9,879	Closed	-$2.22M	–	2127
2022 Q3	$2.22M	Buy	+9,879	New	+$2M	0.09%	350
2022 Q2	–	Sell	-3,400	Closed	-$431K	–	2114
2022 Q1	$431K	Buy	+3,400	New	+$383K	0.02%	880

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Jump Financial's KRTX Position: Q1 2024 in Review

Jump Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,170 shares — an estimated $370K sold.

Jump Financial first reported a position in KRTX in Q1 2022 and held it in 5 quarters. The position peaked at $2.22M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Jump Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Jump Financial sold 1,170 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $370K.
Jump Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Jump Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $2.22M in Q3 2022.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jump Financial's 13F filing for Q1 2024, filed 13 May 2024.